Pharmaceuticals

Imperial College London is a hive of activity in drug discovery and development. Imperial hosts some of the world’s leading scientists as well as the affiliation with Imperial NHS trust, one of the largest academic health systems in Europe.

Based on these cutting edge capabilities, ICON has a proven record in assisting pharmaceutical companies and CROs to develop successful, ground-breaking medicines.

Our consultants are key opinion leader physicians and globally renowned researchers, who are committed to translating their expertise into practice in order to push the boundaries of drug development.

We have helped clients solve a range of problems:

 

SCIENTIFIC AND REGULATORY ADVICE AND PROTOCOL ASSISTANCE

Our academics have offered scientific, regulatory advice as well as assistance with clinical trial protocols in all therapeutic classes including rare diseases.`

 

PRE-CLINICAL DEVELOPMENT

Validated disease models in multiple therapeutic areas, high throughput screening, assays, pre-clinical species PK/PD, imaging, medicinal chemistry, structural synthesis pathways and lead optimisation strategy.

 

VACCINE DEVELOPMENT

Identification of antigens, reverse vaccinology, vaccine challenge tests for RSV, malaria and influenza.

 

MOLECULAR DIAGNOSTICS UNIT (MDU)

The CPA-accredited Molecular Diagnostic Unit (MDU) provides fast, accurate diagnostic tests for the management of infectious and genetic diseases using latest technology, including next generation sequencing and UPLC. Through ongoing research and development of new diagnostic methods it strives to remain ahead of the field in diagnostic testing and clinical monitoring.

The MDU supports the HIV and HTLV trials of the Clinical Trials Centre and patient management for The National Centre for Human Retrovirology and Imperial College Healthcare Trust.

Work to date has been centred on HIV, hepatitis viruses and sexually transmitted infections – but the clinical requirements of other clients can be catered for, click for more details

 

 

ACCESS TO FACILITIES

Genomics, biomarker discovery, high throughput mass spec, NMR, X-ray crystallography, advanced PET, advanced MRI, functional MRI and quantitative image analysis using AI.

Whether you need help with pre/clinical development or access to cutting edge validated assays and disease models, we can find the right people to help you solve a problem flexibly and responsively.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Who to contact:

Poh-Choo Pang

Poh-Choo Pang

Engagement Manager

For Clinical Sciences, Medicine, Chemistry, Bio-Sciences, Biochemistry, Bio-tech, Ecology, Microbiology, Physics

Tel: +44 (0)20 7594 6557

Email me

All areas of expertise:

Related Insights

Do bots spread fake news?

Do bots spread fake news?

If bots aren’t responsible for spreading fake news, could automated systems form part of the solution, helping to identify false stories and check their spread? read more

Life after lockdown: Health and healthcare

Life after lockdown: Health and healthcare

As the first volunteer receives Imperial’s COVID-19 vaccine – academics from across Imperial are working on solutions to take us past the pandemic into life after lockdown. read more

Imperial’s COVID-19 vaccine

Imperial’s COVID-19 vaccine

As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, the team leading this pioneering work talk though the science of the vaccine and how they will find out whether it protects people from the disease. read more

Related case studies

Bio-Inspired Aerial Robotics

Bio-Inspired Aerial Robotics

Dr Mirko Kovac is Director of the Aerial Robotics Laboratory at Imperial College London, and Senior Lecturer in Aero-structures. His research focuses on the development of biologically inspired flying robots for distributed sensing of air and water, search and rescue plus autonomous repair and construction. read more

Putting science into Sci-Fi

Putting science into Sci-Fi

When Left Bank Pictures (producers of The Crown and Lost) were looking for someone to give their Sci fi adventure, ORIGIN, a touch of realism - they called upon Imperial Consultants. Thanks to his previous work with filmmakers, writers and artists, they were introduced to Dr Roberto Trotta, a theoretical cosmologist renowned for taking on the unusual - and gifted in translating ‘science-speak’ into layman’s terms. read more

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Latest news

FREE Fetal Growth Restriction webinar

FREE Fetal Growth Restriction webinar

Available ON DEMAND. First of four, educational webinars exploring a multi-disciplinary approach to Fetal Medicine delivered by international experts, led by Imperial College London’s Professor Christoph Lees, and supported by GE HealthCare. read more

New freshwater control system may resolve flood challenges

New freshwater control system may resolve flood challenges

A new river control system that uses smart technology has been shown to reduce downstream flooding, in a consultancy project carried out by Dr Wouter Buytaert for PyTerra. read more

Energy tech helping UK meet net zero emissions

Energy tech helping UK meet net zero emissions

Studies by Imperial's academics for energy companies Drax and SSE Renewables offer expert insight into the energy technologies that could help the UK meet its target of net zero carbon dioxide emissions by 2050. read more